Investor profile
Alychlo has backed 6 European tech companies across 9 funding rounds between 2017 and 2025, joining rounds totalling €245M. Most active in Software and Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Lizy | Belgium | 3 | €127M |
| EnergyVision | Belgium | 2 | €47M |
| Midiagnostics | Belgium | 1 | €30M |
| Sophia Genetics | Switzerland | 1 | €26M |
| Itineris | Belgium |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Lizy | Other | €75M | 2025-08 |
| Lizy | Series A | €40M | 2022-10 |
| Midiagnostics | Series D+ | €30M | 2024-12 |
| EnergyVision |
| 1 |
| €16M |
| Ebusco | Netherlands | 1 | €0 |
| €27M |
| 2022-04 |
| Sophia Genetics | Series D+ | €26M | 2017-07 |
| EnergyVision | Other | €20M | 2022-01 |
| Itineris | Other | €16M | 2022-04 |
| Lizy | Other | €12M | 2024-02 |
